Whereas immunocompetent mice are able to reject cancer cell lines overexpressing the ARIH1 E3 ligase, immunocompromised mice are not, reinforcing the crucial role of ARIH1-ubiquitin-dependent pathways in anti-tumor immunity [221]. Here, ARIH1 is linked to cancer.